4//SEC Filing
GLECKEL LOUIS MD 4
Accession 0001493152-22-018603
CIK 0000868278other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 7:51 PM ET
Size
5.8 KB
Accession
0001493152-22-018603
Insider Transaction Report
Form 4
GLECKEL LOUIS MD
10% Owner
Transactions
- Award
Option (right to buy)
2022-07-01+40,000→ 40,000 totalExercise: $12.92Exp: 2029-07-01→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal quarterly installments over one year, with the first quarterly installment to vest on September 30, 2022 and each additional installment to vest quarterly thereafter, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of July 1, 2022.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeother
Related Parties
1- filerCIK 0001164762
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 7:51 PM ET
- Size
- 5.8 KB